Gishirin lithium na Heparin CAS:9045-22-1
Babu wani bambanci mai mahimmanci a kididdiga a cikin sakamakon gano TP, ASO, UA, ALT, Mg, Cl, TC, CRP tsakanin heparin lithium anticoagulant plasma da serum (P>0.05). Akwai bambanci mai mahimmanci a kididdiga a cikin sakamakon gano HBD, LDH, da TChemicalbookBA tsakanin heparin lithium anticoagulant plasma da serum (P<0.05). Saboda haka, ban da HBD, LDH, da TBA, alaƙar da ke tsakanin heparin lithium anticoagulant plasma da serum yana da kyau. Saboda haka, yuwuwar amfani da heparin lithium anticoagulant plasma maimakon serum a gwajin rayuwa ta yau da kullun yana da yawa, kuma ana iya amfani da shi azaman hanyar ganowa mai mahimmanci, kuma ana iya amfani da shi azaman hanyar ganowa mai mahimmanci..
| Tsarin aiki | NA |
| Gwaji | 99% |
| Bayyanar | Foda fari |
| Lambar CAS | 9045-22-1 |
| shiryawa | Ƙarami da girma |
| Rayuwar shiryayye | Shekaru 2 |
| Ajiya | A adana a wuri mai sanyi da bushewa |
| Takardar shaida | ISO. |
Rubuta saƙonka a nan ka aika mana da shi








